[an error occurred while processing this directive]
BBC News
watch One-Minute World News
Last Updated: Monday, 26 June 2006, 10:11 GMT 11:11 UK
Drug firms attacked on marketing
Drug firms' annual marketing spend is $60bn, the report says
Top European pharmaceutical firms are using unscrupulous marketing practices to promote their products, a consumer report says.

The Consumers International lobby group accused drugmakers of using the methods to get doctors to prescribe products and persuade consumers they need them.

It said there was a "shocking" lack of publicity about where the $60bn (33bn) annual marketing spend went.

Drug firms say that they act within strict guidelines.

The Association of the British Pharmaceutical Industry (ABPI) told the BBC News website that for UK-based firms there was "a stringent and transparent code of practice that goes beyond the requirements of UK law and the industry regulator".


Consumers International said it had analysed the selling techniques of many leading companies, including Bayer, GlaxoSmithKline and Johnson & Johnson.

The current regulatory framework is clearly insufficient to prevent systemic violations of marketing regulations
Consumers International

Richard Lloyd, the group's director general, said: "The pharmaceutical industry spends nearly twice as much on marketing as it does on research and development, yet consumers know next to nothing about where this money is going."

He called for a revision of marketing regulations to achieve "more transparency from drug companies".

In most Western markets direct advertising to consumers is banned.

But Mr Lloyd said there were other methods drug companies were using to influence opinion.

These include the sponsoring of patient lobby groups, funding disease awareness campaigns and use of hospitality packages for medical experts.

As producers of life-saving medicines it is important that we ensure doctors know full details

The report cites sponsorships by such firms as Eli Lilly and Pfizer. The latter, the maker of Viagra, sponsored a campaign by the Impotence Association which sported the Pfizer logo.

The report said only one of the firms studied, Orion Pharma, provided specific marketing budget information.

It also pointed to the "large numbers of serious, recent and repeated breaches of marketing codes".

This showed the "current regulatory framework is clearly insufficient to prevent systemic violations of marketing regulations".

However, the ABPI said the number of complaints raised showed the system, which had been strengthened this year, was working.

It said complaints from drug companies about fellow firms' activities showed the self-regulation was effective.

But it also said it was vital for doctors to know about products.

"There is no point having innovative new medicines if they remain unused," an association spokesman said.

Drug firms 'inventing diseases'
11 Apr 06 |  Health
Bad Medicine
12 Jul 05 |  This World
Africa rises to HIV drug challenge
08 Jun 06 |  Business
Go-ahead for 'pharmed' goat drug
02 Jun 06 |  Science/Nature

The BBC is not responsible for the content of external internet sites

Has China's housing bubble burst?
How the world's oldest clove tree defied an empire
Why Royal Ballet principal Sergei Polunin quit


Americas Africa Europe Middle East South Asia Asia Pacific